Literature DB >> 1318531

Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report.

Y R Mahida1, A C Perkins, M Frier, M L Wastie, C J Hawkey.   

Abstract

The 99Tcm-labelled antigranulocyte antibody BW250/183 has been used in the detection of intestinal inflammation in patients with active ulcerative colitis and Crohn's disease. Planar images were obtained up to 24 h after intravenous injection of the antibody. Eight out of nine patients with ulcerative colitis and six out of seven patients with Crohn's disease gave positive images. In 11 patients distribution of the inflammation was confirmed by barium studies, colonoscopy or surgery, whilst in two the antibody scan suggested more extensive disease than barium enema. None of the patients had any adverse reactions. Imaging with BW250/183 appears to give an accurate indication of the extent of inflammation in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318531     DOI: 10.1097/00006231-199205000-00006

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  3 in total

1.  Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.

Authors:  J W Arndt; M I Grootscholten; R A van Hogezand; G Griffioen; C B Lamers; E K Pauwels
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

2.  Technetium-99m scintigraphy: more accurate assessment of ulcerative colitis with exametazime-labelled leucocytes than with antigranulocyte antibodies.

Authors:  S Almers; G Granerus; L Franzén; M Ström
Journal:  Eur J Nucl Med       Date:  1996-03

3.  Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease.

Authors:  M Papos; F Nagy; G Narai; M Rajtar; G Szantai; J Lang; L Csernay
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.